🔎 Trials Near Me

Home › Sakit ni Alzheimer › Florida › Orlando

Pag-aaral pangklinika para sa Sakit ni Alzheimer sa Orlando, FL

Isang pag-aaral para sa Sakit ni Alzheimer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Orlando. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Nagre-recruitPhase 2
  • Clinical Site, Orlando
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Nagre-recruitPhase 2
  • K2 Medical Research, Maitland · 6 mi ang layo
Edad 55 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Nagre-recruitPhase 3
  • Local Institution - 1635, Orlando
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06937229

A Study of LY3439539 in Participants With Alzheimer's Disease

Nagre-recruitPhase 1
  • Charter Research, Orlando
  • AdventHealth Orlando, Orlando
  • K2 Medical Research, Maitland · 6 mi ang layo
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07598370

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Nagre-recruitPhase 3
  • Charter Research Orlando, Orlando
  • Nova Psychiatry, Orlando
  • Combined Research Orlando Phase I-IV LLC, Orlando
  • at 1 pa
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06585787

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Nagre-recruitPhase 2
  • Charter Research - Orlando, Orlando
  • Conquest Research, Winter Park · 5 mi ang layo
  • K2 Medical Research ORLANDO, Maitland · 6 mi ang layo
Edad 55 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589595

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Nagre-recruitPhase 2
  • Conquest Research - Lake Nona, Orlando
Edad 55 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Nagre-recruitPhase 3
  • Charter Research - Winter Park/Orlando, Orlando
  • Conquest Research - Lake Nona, Orlando
  • Conquest Research, LLC, Winter Park · 5 mi ang layo
  • at 2 pa
Edad 50 hanggang 90 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07177352

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

Nagre-recruitPhase 1/2
  • Conquest Research - Winter Park /ID# 277760, Winter Park · 5 mi ang layo
  • K2 Medical Research - Clermont /ID# 277859, Clermont · 24 mi ang layo
Edad 50 hanggang 90 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07599670

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Nagre-recruitPhase 3
  • Combined Research Orlando (CRO), Orlando
  • Local Institution - 1622, Maitland · 6 mi ang layo
  • Local Institution - 1631, Maitland · 6 mi ang layo
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Nagre-recruitPhase 3
  • Local Institution - 2634, Orlando
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07011745

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

Nagre-recruitPhase 3
  • K2 Medical Research, LLC, Maitland · 6 mi ang layo
Edad 55 hanggang 80 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07717411

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Nagre-recruitPhase 2
  • ClinCloud, Maitland · 6 mi ang layo
  • Local Institution - 0007, Maitland · 6 mi ang layo
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Nagre-recruitPhase 2
  • Charter Research - Orlando ( Site 1051), Orlando
  • Conquest Research LLC ( Site 1053), Winter Park · 5 mi ang layo
  • K2 Medical Research ( Site 1047), Maitland · 6 mi ang layo
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07033494

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Nagre-recruitPhase 1
  • K2 Medical Research, LLC, Maitland · 6 mi ang layo
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06297590

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Nagre-recruitPhase 1/2
  • Charter Research, LLC, Orlando
  • Headlands Horizons LLC, Orlando
Edad 35 hanggang 85 · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05462106

Low-Dose Radiotherapy for Alzheimer's Disease

Nagre-recruitPhase 1/2
  • Renaissance Institute of Precision Oncology & Radiosurgery, Winter Park · 5 mi ang layo
Edad 50 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07693140

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Nagre-recruitPhase 3
  • Charter Research - Orlando, Orlando
  • Headlands Research Orlando, Orlando
  • Conquest Research, Winter Park · 5 mi ang layo
  • at 1 pa
Edad 55 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Nagre-recruitPhase 2
  • Conquest Research, Winter Park · 5 mi ang layo
  • K2 Medical Research LLC, Maitland · 6 mi ang layo
  • K2 Medical Research LLC, Maitland · 6 mi ang layo
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT07094516

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
  • K2 Medical Research, Maitland · 6 mi ang layo
Edad 45 hanggang 85 · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06657768

[18F]PI-2620 Phase 3 Histopathological Study

Nagre-recruitPhase 3
  • Charter Research, Winter Park · 5 mi ang layo
  • K2 Medical Research, Maitland · 6 mi ang layo
Edad 50 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT05641688

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Charter Research, Orlando
  • Conquest Research, Winter Park · 5 mi ang layo
  • K2 Medical Research, Maitland · 6 mi ang layo
  • at 1 pa
Edad 60 hanggang 90 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT06584357

Open-label Extension Study in Participants With Early Alzheimer's Disease

Nagre-recruitPhase 2
  • GSK Investigational Site, Maitland · 6 mi ang layo
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT07105709

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Nagre-recruit
  • Advent Health, Orlando
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Ene 9, 2026 · NCT03671889

University of Central Florida CereBank

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • University of Central Florida, Orlando
Edad 18 pataas · Kababaihan · Na-update Mar 14, 2025 · NCT06876857

Pag-aaral para sa Sakit ni Alzheimer sa ibang lungsod

Iba pang pag-aaral sa Orlando

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.